← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 1977Last known activity
Aug 1, 2025
Timeline
1950s
- Jan 1, 1957
NSABP Foundation— Founded
Drugs by trial phase (65 distinct, 69 trials)
Phase 3 (43 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Breast Neoplasms
- Carcinoma
- Carcinoma, Ductal
- Carcinoma in Situ
- Carcinoma, Intraductal, Noninfiltrating
- Cardiovascular Diseases
- Colonic Neoplasms
- Colorectal Neoplasms
- Coronary Disease
- Heart Diseases
- Ischemia
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasm, Residual
- Neoplasms
- Precancerous Conditions
- Rectal Neoplasms
- Triple Negative Breast Neoplasms
Recent trials (50)
- NCT07058012Lead sponsorPhase 2Aug 1, 2025
- NCT05178576Lead sponsorPhase 2Jun 24, 2022
- NCT05178576Overall official - principal investigatorPhase 2Jun 24, 2022
- NCT04622319CollaboratorPhase 3Nov 30, 2020
- NCT04024800CollaboratorPhase 2May 3, 2019
- NCT04024800Reponsible party - principal investigatorPhase 2May 3, 2019
- NCT04024800Overall official - principal investigatorPhase 2May 3, 2019
- NCT03628066Overall official - principal investigatorPhase 2Sep 15, 2018
- NCT03628066Lead sponsorPhase 2Sep 15, 2018
- NCT03626922Overall official - principal investigatorPhase 1Aug 31, 2018
- NCT03626922Lead sponsorPhase 1Aug 31, 2018
- NCT03457896Lead sponsorPhase 2May 18, 2018
- NCT03457896Overall official - principal investigatorPhase 2May 18, 2018
- NCT03412643Lead sponsorPhase 2May 14, 2018
- NCT03412643OfficialPhase 2May 14, 2018
Details
- Founded
- Pittsburgh, PA, US Jan 1, 1957
- Last known activity
- Aug 1, 2025